Stock Track | Thermo Fisher Scientific Soars 5.23% in Pre-Market After Q2 Earnings Beat

Stock Track
Jul 23

Thermo Fisher Scientific's stock soared 5.23% in pre-market trading on Thursday, following the release of its second-quarter 2026 financial results.

The company reported adjusted earnings per share of $6.03, beating the analyst consensus estimate of $5.71 by 5.6%. Revenue came in at $11.994 billion, surpassing expectations of $11.701 billion by 2.5%. This represents a 10% year-over-year increase in revenue and a 13% rise in adjusted EPS.

The strong quarterly performance was driven by robust customer activity across the company's end markets, successful new product launches including next-generation mass spectrometry platforms and PCR systems, and strategic collaborations. The earnings beat also helped the stock recover from recent sector-wide weakness, as the life sciences tools sector had faced selling pressure earlier in the week.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10